Gynae & Infertility

BRCA Mutation

NIPT (Non-Invasive Prenatal Tet)

CES (Clinical Exom Sequencing)

WES (Whole Exom Sequencing)

NBS (New Born Screening)

PND for Beta Thalassemia Mutation

CMA (Chromosomal Micro Array)

RPL – Panel
Gynae & Infertility
TEST NAME
|
FULL NAME
|
SHORT DESCRIPTION
|
---|---|---|
NIPT NGS- ILLUMINA PLATFORM
|
NON-Invasive Prenatal Test (T21, T13, T18 (+ Other chromosomes)
|
Non Invasive Screening test for chromosomal aneuploidy of fetus in pregnant woman @ 10 th weeks of gestation. This test should not be considered diagnostic. Maternal whole blood 10 ml in Streck tube is sample type
|
CMA
|
Chromosome Microarray - All chromosmes. Gain or loss of any chromosme. triploidy of any chromosome.
|
This enables the detection of aneuploidies, submicroscopic aberrations, and mosaic events. Also, due to the ability to provide genotype information, it can help in the identification of triploidies, and copy neutral events such as absence of heterozygosity and UPD.
|
BRCA 1 & 2
|
Breast & Ovarian cancer genetic mutation
|
--
|
WES by NGS followed by Sanger sequencing
|
Whole Exom Sequencing For Rare Genetic Diagnosis
|
Clinical exome sequencing (CES) is rapidly becoming a common molecular
diagnostic test for establishing a definitive molecular diagnosis of individuals with rare genetic disorders which can allow for: -Better understanding of the natural history/prognosis -Targeted management (anticipatory guidance, management changes, specific therapies) -Predictive testing of at-risk family members -Testing and exclusion of disease in siblings or other relatives -Recurrence risk assessment -Reproductive decision-making Serving as a second-tier test for patients in whom previous genetic testing for specific syndromes was negative Providing a potentially cost-effective alternative to establishing a molecular diagnosis compared to multiple independent molecular assays |
Karyotyping (Periferal blood/ Amniotic Fluid)
|
All Chromosome Analyses
|
To diagnose congenital chromosomal abnormalities, including aneuploidy, structural abnormalities, and balanced rearrangements
|
RPL Panel
|
Repeated Pregnancy Loss
|
Test helps in identification of possible reason for pregnancy loss.
|
Y-Chromosome Microdeletion
|
--
|
Yq microdeletions involving some or all of the azoospermic factor (AZF) region are the most frequently identified cause of spermatogenic failure in chromosomally normal men with nonobstructive azoospermia (3%-15%) or severe oligospermia (6%-10%). Among unselected infertile males, the overall frequency of Yq microdeletions is approximately 3%. The relative frequency of Yq microdeletions makes the evaluation for them an important aspect of the diagnostic work up in infertile males, especially those with azoospermia or severe oligospermia. Most cases of Yq microdeletions occur de novo, and due to the consequential infertile phenotype, they are typically not transmitted. However, in cases where assisted reproductive technology (example: testicular sperm extraction followed by intracytoplasmic sperm injection) is used to achieve viable pregnancy, all male offspring born to a microdeletion carrier will carry the deletion and may be infertile. Men testing positive for 1 or more microdeletions who are enrolled in an in vitro fertilization treatment program may wish to consider alternative options to intracytoplasmic sperm injection (eg, donor sperm) and consultation with an experienced reproductive endocrinologist and medical geneticist is recommended. Most Y microdeletions are the result of homologous recombination between repeated sequence blocks. Testing for deletions involves investigating for the presence or absence of markers located within nonpolymorphic regions of the AZF region.
|
NBS-Right start
|
--
|
--
|
TMS
|
New Born Screening
|
--
|
TMS & GCMS
|
100 + Condition
|
--
|
Prenatal - Beta thalassemia gene sequencin
|
--
|
Detection of pathogenic mutations in a DNA sample can lead to a diagnosis, possible prognosis, and prospective therapy treatments. And fetal diagnosis.
|
Our Latest Technology














Sample Collection Center

CHATTOGARAM
Address:106/A (3rd Floor), K.B. Fazlul Kader Road
Pabortak Mor, Panchlaish, Chattogram-4209
(Infront of Chittagong Medical College Main Gate)
Contact Person: MR. MAMUN HOWLADER
Contact Number: +8801709-918855 Or +8801709-918830
E-mail: ctg_101@labsciencebd.com

COX’S BAZAR
Address:Banani Bhabon (1st Floor), Room No. 5
Main Road, Bazar Ghata, Cox’s Bazar
Contact Person: MR. YASIR ARAFAT
Contact Number: +8801709-918858 Or +8801709918830
E-mail: cox_101@labsciencebd.com

SYLHET
Address:Chouhatta Mor, Sylhet
Contact Number: +8801742-383381
E-mail: sylhet_101@labsciencebd.com